UAE Life Sciences Localization Is Evolving Beyond Manufacturing
Why the UAE opportunity now extends across research, protected health data, AI-enabled discovery, supply chains and commercialization.
Read insight ↗Insights by Fatma AlSabaanah
Clear thinking for complex pharmaceutical decisions.
Personal analysis on market entry, regulatory strategy, access, portfolios and partnership execution.
Latest thinking
Strategy becomes useful when it changes the next decision.
These articles reflect how I connect disciplines that are often discussed separately. They are educational perspectives, not company promotion or jurisdiction-specific regulatory advice.
Why Pharmaceutical Market Entry Requires More Than Registration
Registration is essential, but it is only one decision in a connected market-entry system.
Read insight ↗Connecting Regulatory Strategy with Market Access and Portfolio Decisions
Regulatory, access and portfolio choices are strongest when they are made from one shared opportunity thesis.
Read insight ↗Building Pharmaceutical Partnerships Around Clear Roles and Execution
Strong pharmaceutical partnerships are built on explicit ownership, decision rights and operating discipline—not goodwill alone.
Read insight ↗